ADVERSE EFFECTS OF LINCOMYCIN AND SPECTINOMYCIN IN RATS | ||||
| Mansoura Veterinary Medical Journal | ||||
| Article 32, Volume 18, Issue 1, June 2017, Page 503-519 PDF (3.1 MB) | ||||
| DOI: 10.21608/mvmj.2017.127611 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| S. A Amer* 1; Reham A. A2; Enjy F. R3; Hamza H M2 | ||||
| 1Pharmacology Department, Fac. Vet. Med, Mansoura University | ||||
| 2Pharmacology Department, Fac. Vet. Med, | ||||
| 3Clinical Pathology Department., Fac. Vet. Med., Mansoura University | ||||
| Abstract | ||||
| This study was performed to investigate the adverse effects of lincomycin (given orally at 500 mg/kg daily for 21 days) and spectinomycin (given S.C at 250 mg/kg daily for 30 days) on 24 apparently clinically healthy adult male albino rats (175 - 250 gm). Blood, serum and tissues (Liver, kidney and testis) samples were collected for hematological, biochemical and histopathological for investigation. The obtained results revealed that, lincomycin and spectinomycin treated groups showed a significant decrease in total erythrocytic and leucocytic count (especially lymphocytes), hemoglobin values and PCV value. The levels of ALT, AST, cholesterol, triglycerides and LDL revealed a significant increase in lincomycin and spectinomycin treated groups. While the level of HDL showed a significant decrease in both lincomycin and spectinomycin treated groups. The results also showed that, both drugs induced histopathological alterations in the liver, kidney and testis. | ||||
| Keywords | ||||
| LINCOMYCIN; SPECTINOMYCIN; RATS | ||||
|
Statistics Article View: 206 PDF Download: 181 |
||||
